Developing an Oncology Workforce for the 21st Century

描述(由申请者提供)：芝加哥大学早就认识到内科科学家的重要性，他们能够利用实验室发现来发展新的治疗方法，并使用临床观察来提供信息和塑造基础研究。该大学在培养下一代学术肿瘤学家方面有着令人羡慕的记录。然而，对在临床和转化性研究方面具有关键专业知识的学术领袖的培训已变得越来越困难，这要求创建一个结构严密和有指导的培训环境。利用我们目前的培训计划(CTSA、K30奖、非路线图K12奖、传统T32培训、K08/K23指导计划)，我们将在以患者为中心的研究中创建一个跨学科计划，培训临床医生和基础科学家领导跨学科团队，从而改变肿瘤学的实践。保罗卡拉布雷西K12学者计划是我们的高度指导，教学课程密集的计划，并“动手”临床研究培训的结果是在健康研究的科学硕士学位。这些学者是完成团契培训的临床肿瘤学家，希望改变职业重点的临床教师，或拥有与健康相关的博士学位并希望在临床领域工作的科学家。我们的临床课程实力，加上我们的研究强度和对遗传学/基因组学研究的关注，使芝加哥大学成为为个性化医学时代培养临床肿瘤学劳动力的理想机构。通过这一培训计划，将产生真正的翻译研究人员和临床肿瘤学家，他们将拥有进行逐个床边研究的知识和能力，并将他们的研究结果传回给患者和民众。我们期望，完成这一计划的个人将获得所需的广泛研究培训和全面经验，以进行高质量和高影响的基于假说的临床和转化性研究，并为个性化癌症治疗的目标做出基础性贡献。与我们学院的所有培训项目一样，保罗·卡拉布雷西学者项目的一个明确目标是，它的培训机会和好处将远远超出它将提供津贴的相对较少的学者。我们相信，该计划将影响到我们大学和芝加哥更大的肿瘤学实习生社区，以及全球在癌症研究领域寻求职业生涯的年轻科学家。因此，从该计划的实施中获得的好处将是巨大的。

DESCRIPTION (provided by applicant): The University of Chicago has long recognized the importance of physician scientists capable of utilizing laboratory discoveries to evolve novel therapeutic approaches and using clinical observations to inform and shape basic investigations. The University has an enviable record of training the next generation of academic oncologists. However, the training of academic leaders with critical expertise in clinical and translational research has become increasingly difficult, mandating the creation of a tightly structured and mentored training environment. Leveraging our current training programs (CTSA, K30 award, non-Roadmap K12 awards, traditional T32 training, K08/K23 mentoring programs), we will create an interdisciplinary program in patient-oriented research to train clinicians and basic scientists to lead interdisciplinary teams that will transform the practice of oncology. The Paul Calabresi K12 Scholars Program is our highly mentored, didactic coursework-intensive program, and "hands on" clinical research training which results in a Master of Science in Health Studies. These scholars are clinical oncologists finishing fellowship training, clinical faculty who wish to change career emphasis, or a scientist with a health-related PhD who wishes to work in the clinical sphere. The strength of our clinical programs coupled with our research intensity and our focus on genetics/genomics research makes the University of Chicago an ideal institution for the preparation of a clinical oncology workforce for the era of personalized medicine. Through this training program will emerge bonafide translational researchers and clinical oncologists who will possess the knowledge and capacity to conduct bench to bedside research and translate their findings back to patients and the population. It is our expectation that individuals completing this program will have obtained the broad research training and comprehensive experience necessary to perform high quality and high impact hypothesis-based clinical and translational research and to make fundamental contributions towards the goal of personalized cancer treatment. An explicit goal of this Paul Calabresi Scholars program, as with all training programs in our institution, is that its training opportunities and benefits will extend far beyond the relatively few scholars whose stipends it will provide. We are confident that the program will reach into the larger oncology trainee community at our University and in Chicago and to young scientists pursuing careers in cancer research all over the globe. Thus, the benefit that accrues from the program's implementation will be substantial.